NTRK1 and glioblastoma: Recently, studies on genetic alterations in GBM determined three major pathways, that is, a receptor tyrosine kinase (RTK) pathway, a p53 pathway, and a retinoblastoma protein (RB) tumor suppressor pathway, which are involved in the pathogenesis of GBM [37].